+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

IVF Services Market by Cycle Type and End User: Global Opportunity Analysis and Industry Forecast, 2019-2026

  • PDF Icon

    Report

  • 742 Pages
  • October 2019
  • Region: Global
  • Allied Market Research
  • ID: 4621178
Description Jump to:
The global IVF services revenue market generated $12,506 million in 2018, and is projected to reach $25,563 million by 2026, growing at a CAGR of 9.3% from 2019 to 2026. In vitro fertilization is an assisted reproductive technology, which involves retrieving eggs from a woman’s ovaries and fertilizing them with sperm outside the body, in vitro.



Rise in infertility rate, an increase in trend of delayed pregnancies, a surge in IVF success rate, and rise in disposable income worldwide are the factors that are anticipated to boost the growth of the global IVF services market during the forecast period. However, factors such as complications associated with IVF treatment, high cost, and low awareness level for IVF in some underdeveloped regions hinder the growth of the market. Conversely, an increase in fertility tourism and a surge in number of fertility clinics are anticipated to offer lucrative opportunities for market growth in the near future.

The global IVF services market is segmented into cycle type, end user, and region. Depending on cycle type, the market is divided into fresh IVF cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. According to end user, it is classified into fertility clinics, hospitals, surgical centers, and clinical research institutes. Region wise, it is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia, Denmark, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, Thailand, New Zealand, South Korea, and rest of Asia-Pacific), and LAMEA (Latin America, Middle East, and Africa).

KEY BENEFITS FOR STAKEHOLDERS
  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Comprehensive analysis of all regions is provided to determine the prevailing opportunities.
  • Key players are profiled to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Cycle Type
  • Fresh IVF Cycles (Non-donor)
  • Thawed IVF Cycles (Non-donor)
  • Donor Egg IVF Cycles

By End User
  • Fertility Clinics
  • Hospitals
  • Surgical Centers
  • Clinical Research Institutes

By Region

North America
  • U.S.
  • Canada
  • Mexico

Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Denmark
  • Russia
  • Rest of Europe

Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • New Zealand
  • Thailand
  • Rest of Asia-Pacific

LAMEA
  • Latin America
  • Middle East
  • Africa

LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • Ambroise Paré Group
  • amedes MVZ Cologne GmbH
  • AMP Center St Roch
  • AVA Clinic Scanfert
  • Bangkok IVF center
  • Bangkok IVF center (Bangkok Hospital)
  • Betamedics
  • Biofertility Center
  • Bloom Fertility and Healthcare
  • Bloom Fertility Center
  • Bourn Hall Fertility Center
  • Bourn Hall International
  • Cardone Reproductive Medicine and Infertility, LLC
  • Center for Advanced Reproductive Medicine and Infertility
  • CHA Fertility Center
  • Chelsea and Westminster Hospital (Assisted Conception Unit)
  • Cloudnine Fertility
  • Conceptions Reproductive Associates of Colorado
  • Cyprus IVF Centre
  • Dansk Fertilitetsklinik
  • EUVITRO S.L.U.
  • Fakih IVF Fertility Center
  • Fertility and Gynecology Center Monterey Bay IVF
  • Fertility Associates
  • Fertility Center Berlin
  • Fertility Center of San Antoni
  • Fertility First
  • FIV Marbella
  • Fivet Centers Prof. Zech
  • Flinders Reproductive Medicine Pty Ltd
  • Genea Oxford Fertility Limited
  • Heidelberg University Hospital
  • Houston Fertility Center
  • International Centre for Reproductive Medicine, ICRM
  • IVF Canada
  • IVF NAMBA Clinic
  • IVF Panama Center for Reproduction Punta Pacífica
  • IVF Spain
  • IVI Panama
  • Ivinsemer
  • KL Fertility & Gynaecology Centre
  • Lifesure Fertility and Gynaecology Centre
  • LIV Fertility Center
  • Manipal Fertility
  • Maria Fertility Hospital
  • MD Medical Group
  • Medfem Fertility Clinic
  • Monash IVF Wesley Hospital Auchenflower
  • Morpheus Life Sciences Pvt. Ltd.
  • New hope fertility center
  • Oak Medical Group/Oak Clinic
  • OVA IVF Clinic Zurich
  • Procrea Fertility
  • RAPRUI Srl
  • Repromed
  • SAFE Fertility Center
  • Sanno Hospital
  • Servy Massey Fertility Institute
  • Shanghai Ji Ai Genetics & IVF Institute
  • Shanghai United Family Hospital
  • Sher Institute for Reproductive Medicine (SIRM)
  • Southend Fertility and IVF
  • StorkKlinik (Stork IVF Clinic)
  • The ARC-STER Center
  • The Bridge Centre
  • The Cape Fertility Clinic
  • The Hugh Wynter Fertility Management Unit
  • The Lister Fertility Clinic
  • The Montreal Fertility Center
  • Thomson Medical Pte. Ltd.
  • Trianglen Fertility Clinic
  • TRIO Fertility
  • Virtus Health
  • Vitanova
  • VivaNeo - Medical Center Kinderwens
  • Wunschkinder

Table of Contents

Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models
Chapter 2: Executive Summary
2.1. Key Findings of The Study
2.2. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Ivf Pricing Trends
3.3. Ivf Cycles By Country
3.4. Global Ivf Services Market, By End User
3.4.1. Market Size And Forecast
3.4.2. Market Volume And Forecast
3.4.3. Fertility Clinics
3.4.3.1. Market Size And Forecast
3.4.4. Hospitals
3.4.4.1. Market Size And Forecast
3.4.5. Surgical Centers
3.4.5.1. Market Size And Forecast
3.4.6. Clinical Research Institutes
3.4.6.1. Market Size And Forecast
3.5. Global Ivf Services Market By Cycle Type
3.5.1. Market Size And Forecast
3.5.2. Market Volume And Forecast
3.5.3. Fresh Ivf Cycles (Non-Donor)
3.5.3.1. Market Size And Forecast
3.5.4. Thawed Ivf Cycles (Non-Donor)
3.5.4.1. Market Size And Forecast
3.5.5. Donor Egg Ivf Cycles
3.5.5.1. Market Size And Forecast
3.6. Market Dynamics
3.6.1. Drivers
3.6.1.1. Delayed Pregnancies In Women
3.6.1.2. Increase In Global Infertility Rates
3.6.1.3. Increase In Gamete Donations
3.6.1.4. Increase In Disposable Income
3.6.1.5. Increase In Ivf Success Rates
3.6.1.6. Surge In Healthcare Expenditure Worldwide
3.6.2. Restraints
3.6.2.1. Cost Constraints
3.6.2.2. Complications Associated With Ivf Treatment
3.6.2.3. Low Awareness Level
3.6.3. Opportunities
3.6.3.1. Fertility Tourism
3.6.3.2. Growth Opportunities In The Emerging Markets
3.6.3.3. Increase In Number of Fertility Clinics
3.6.3.4. Rise In Same Sex Marriage
3.6.4. Impact Analyses
3.7. Key Findings
Chapter 4: North America Ivf Services Market
4.1. Overview
4.1.1. Market Size And Forecast
4.1.1.1. By Country
4.1.1.2. By End User
4.1.1.3. By Cycle Type
4.1.2. Market Volume And Forecast
4.1.2.1. By Country
4.1.2.2. By End User
4.1.2.3. By Cycle Type
4.2. U.S. Ivf Services Market, (Revenue And Number of Cycles)
4.2.1. Overview
4.2.2. Market Size And Forecast
4.2.3. Fertility Clinics In U.S., 2016
4.2.4. U.S. Ivf Services Market, By End User
4.2.4.1. Market Size And Forecast
4.2.4.2. Market Volume And Forecast
4.2.4.3. Fertility Clinics
4.2.4.4. Hospitals
4.2.4.5. Surgical Centers
4.2.4.6. Clinical Research Institutes
4.2.5. U.S. Ivf Services Market, By Cycle Type
4.2.5.1. Market Size And Forecast
4.2.5.2. Market Volume And Forecast
4.2.5.3. Fresh Ivf Cycles (Non-Donor)
4.2.5.4. Thawed Ivf Cycles (Non-Donor)
4.2.5.5. Donor Egg Ivf Cycles
4.2.6. Market Dynamics
4.2.6.1. Driving Factors
4.2.6.1.1. Increasing Popularity of Ivf In U.S.
4.2.6.1.2. Increased Rate of Infertility And Practices of Embryo Banking Cycles
4.2.6.2. Restraining Factors
4.2.6.2.1. High Cost of Ivf Treatment In U.S.
4.2.6.2.2. Restrictions On 3-Parent Ivf Treatments
4.2.6.2.3. Scattered Reimbursements
4.2.7. Regulatory Issues, Legislations And Authorities
4.2.8. Insurance Reimbursement Scenario
4.2.9. Company Profiles
4.2.9.1. Fertility And Gynecology Center Monterey Bay Ivf
4.2.9.1.1. Company Overview
4.2.9.2. Conceptions Reproductive Associates of Colorado
4.2.9.2.1. Company Overview
4.2.9.3. Servy Massey Fertility Institute
4.2.9.3.1. Company Overview
4.2.9.4. Sher Institute For Reproductive Medicine (Sirm)
4.2.9.4.1. Company Overview
4.2.9.5. Cardone Reproductive Medicine And Infertility, Llc
4.2.9.5.1. Company Overview
4.2.9.6. Fertility Center of San Antoni
4.2.9.6.1. Company Overview
4.2.9.7. Houston Fertility Center
4.2.9.7.1. Company Overview
4.2.9.8. New Hope Fertility Center
4.2.9.8.1. Company Overview
4.3. Canada Ivf Services Market, (Revenue And Number of Cycles)
4.3.1. Overview
4.3.2. Market Size And Forecast
4.3.3. Ivf Clinics In Canada
4.3.4. Canada Ivf Services Market, By End User
4.3.4.1. Market Size And Forecast
4.3.4.2. Market Volume And Forecast
4.3.4.3. Fertility Clinics
4.3.4.4. Hospitals
4.3.4.5. Surgical Centers
4.3.4.6. Clinical Research Institutes
4.3.5. Canada Ivf Services Market, By Cycle Type
4.3.5.1. Market Size And Forecast
4.3.5.2. Market Volume And Forecast
4.3.5.3. Fresh Ivf Cycles (Non-Donor)
4.3.5.4. Thawed Ivf Cycles (Non-Donor)
4.3.5.5. Donor Egg Ivf Cycles
4.3.6. Market Dynamics
4.3.6.1. Driving Factors
4.3.6.1.1. Commercialization of Ivf Booster In Canada
4.3.6.2. Restraining Factors
4.3.6.2.1. High Cost of Ivf Treatment In Canada
4.3.7. Regulatory Issues, Legislations And Authorities
4.3.8. Insurance Reimbursement Scenario
4.3.9. Company Profiles
4.3.9.1. Trio Fertility
4.3.9.1.1. Company Overview
4.3.9.2. The Montreal Fertility Center
4.3.9.2.1. Company Overview
4.3.9.3. Procrea Fertility
4.3.9.3.1. Company Overview
4.3.9.4. Ivf Canada
4.3.9.4.1. Company Overview
4.4. Mexico Ivf Services Market, (Revenue And Number of Cycles)
4.4.1. Overview
4.4.2. Market Size And Forecast
4.4.3. Fertility Clinics In Mexico
4.4.4. Mexico Ivf Services Market, By End User
4.4.4.1. Market Size And Forecast
4.4.4.2. Market Volume And Forecast
4.4.4.3. Fertility Clinics
4.4.4.4. Hospitals
4.4.4.5. Surgical Centers
4.4.4.6. Clinical Research Institutes
4.4.5. Mexico Ivf Services Market, By Cycle Type
4.4.5.1. Market Size And Forecast
4.4.5.2. Market Volume And Forecast
4.4.5.3. Fresh Ivf Cycles (Non-Donor)
4.4.5.4. Thawed Ivf Cycles (Non-Donor)
4.4.5.5. Donor Egg Ivf Cycles
4.4.6. Market Dynamics
4.4.6.1. Driving Factors
4.4.6.1.1. Fertility Tourism
4.4.6.1.2. Comparatively Low Cost of Ivf
4.4.6.2. Restraining Factors
4.4.6.2.1. Language Barriers
4.4.7. Regulatory Issues, Legislations And Authorities
4.4.8. Insurance Reimbursement Scenario
4.4.9. Company Profiles
4.4.9.1. Liv Fertility Center
4.4.9.1.1. Company Overview
4.4.9.2. Biofertility Center
4.4.9.2.1. Company Overview
4.4.9.3. Ivinsemer
4.4.9.3.1. Company Overview
Chapter 5: Europe Ivf Services Market
5.1. Overview
5.1.1. Market Size And Forecast
5.1.1.1. By Country
5.1.1.2. By End User
5.1.1.3. By Cycle Type
5.1.2. Market Volume And Forecast
5.1.2.1. By Country
5.1.2.2. By End User
5.1.2.3. By Cycle Type
5.2. Germany Ivf Services Market, (Revenue And Number of Cycles)
5.2.1. Overview
5.2.2. Market Size And Forecast
5.2.3. Fertility Clinics In Germany
5.2.4. Germany Ivf Services Market, By End User
5.2.4.1. Market Size And Forecast
5.2.4.2. Market Volume And Forecast
5.2.4.3. Fertility Clinics
5.2.4.4. Hospitals
5.2.4.5. Surgical Centers
5.2.4.6. Clinical Research Institutes
5.2.5. Germany Ivf Services Market, By Cycle Type
5.2.5.1. Market Size And Forecast
5.2.5.2. Market Volume And Forecast
5.2.5.3. Fresh Ivf Cycles (Non-Donor)
5.2.5.4. Thawed Ivf Cycles (Non-Donor)
5.2.6. Market Dynamics
5.2.6.1. Driving Factors
5.2.6.1.1. Subsidizing Ivf Treatments
5.2.6.1.2. Delayed Marriages And Parenthood Decisions
5.2.6.2. Restraining Factors
5.2.6.2.1. Limited Adoption of Ivf Methods
5.2.7. Regulatory Issues, Legislations And Authorities
5.2.8. Insurance Reimbursement Scenario
5.2.9. Company Profiles
5.2.9.1. Heidelberg University Hospital
5.2.9.1.1. Company Overview
5.2.9.2. Wunschkinder
5.2.9.2.1. Company Overview
5.2.9.3. Fertility Center Berlin
5.2.9.3.1. Company Overview
5.2.9.4. Amedes Mvz Cologne Gmbh
5.2.9.4.1. Company Overview
5.3. France Ivf Services Market, (Revenue And Number of Cycles)
5.3.1. Overview
5.3.2. Market Size And Forecast
5.3.3. Ivf Clinics In France
5.3.4. France Ivf Services Market, By End User
5.3.4.1. Market Size And Forecast
5.3.4.2. Market Volume And Forecast
5.3.4.3. Fertility Clinics
5.3.4.4. Hospitals
5.3.4.5. Surgical Centers
5.3.4.6. Clinical Research Institutes
5.3.5. France Ivf Services Market, By Cycle Type
5.3.5.1. Market Size And Forecast
5.3.5.2. Market Volume And Forecast
5.3.5.3. Fresh Ivf Cycles (Non-Donor)
5.3.5.4. Thawed Ivf Cycles (Non-Donor)
5.3.5.5. Donor Egg Ivf Cycles
5.3.6. Market Dynamics
5.3.6.1. Driving Factors
5.3.6.1.1. Rising Adoption of Ivf Babies Among Same Gender Population
5.3.6.1.2. Lower Rates of Fertility
5.3.6.2. Restraining Factors
5.3.6.2.1. Stringent Government Regulations
5.3.7. Regulatory Issues, Legislations And Authorities
5.3.8. Insurance Reimbursement Scenario
5.3.9. Company Profiles
5.3.9.1. Ambroise Par Group
5.3.9.1.1. Company Overview
5.3.9.2. Amp Center St Roch
5.3.9.2.1. Company Overview
5.4. UK Ivf Services Market, (Revenue And Number of Cycles)
5.4.1. Overview
5.4.2. Market Size And Forecast
5.4.3. Fertility Clinics In UK
5.4.4. UK Ivf Services Market, By End User
5.4.4.1. Market Size And Forecast
5.4.4.2. Market Volume And Forecast
5.4.4.3. Fertility Clinics
5.4.4.4. Hospitals
5.4.4.5. Surgical Centers
5.4.4.6. Clinical Research Institutes
5.4.5. UK Ivf Services Market, By Cycle Type
5.4.5.1. Market Size And Forecast
5.4.5.2. Market Volume And Forecast
5.4.5.3. Fresh Ivf Cycles (Non-Donor)
5.4.5.4. Thawed Ivf Cycles (Non-Donor)
5.4.5.5. Donor Egg Ivf Cycles
5.4.6. Market Dynamics
5.4.6.1. Driving Factors
5.4.6.1.1. Commercialization of Three-Parent Ivf Procedures
5.4.6.1.2. Supportive Regulations
5.4.6.2. Restraining Factors
5.4.6.2.1. Ethical Considerations
5.4.7. Regulatory Issues, Legislations And Authorities
5.4.8. Insurance Reimbursement Scenario
5.4.9. Company Profiles
5.4.9.1. The Lister Fertility Clinic
5.4.9.1.1. Company Overview
5.4.9.2. The Bridge Centre
5.4.9.2.1. Company Overview
5.4.9.3. Chelsea And Westminster Hospital (Assisted Conception Unit)
5.4.9.3.1. Company Overview
5.5. Italy Ivf Services Market, (Revenue And Number of Cycles)
5.5.1. Overview
5.5.2. Market Size And Forecast
5.5.3. Italy Ivf Services Market, By End User
5.5.3.1. Market Size And Forecast
5.5.3.2. Market Volume And Forecast
5.5.3.3. Fertility Clinics
5.5.3.4. Hospitals
5.5.3.5. Surgical Centers
5.5.3.6. Clinical Research Institutes
5.5.4. Italy Ivf Services Market, By Cycle Type
5.5.4.1. Market Size And Forecast
5.5.4.2. Market Volume And Forecast
5.5.4.3. Fresh Ivf Cycles (Non-Donor)
5.5.4.4. Thawed Ivf Cycles (Non-Donor)
5.5.4.5. Donor Egg Ivf Cycles
5.5.5. Market Dynamics
5.5.5.1. Driving Factors
5.5.5.1.1. Rise In Medical Tourism
5.5.5.2. Restraining Factors
5.5.5.2.1. Ban On Surrogacy
5.5.6. Regulatory Issues, Legislations And Authorities
5.5.7. Insurance Reimbursement Scenario
5.5.8. Company Profiles
5.5.8.1. The Arc-Ster Center
5.5.8.1.1. Company Overview
5.5.8.2. Raprui Srl
5.5.8.2.1. Company Overview
5.5.8.3. Fivet Centers Prof. Zech
5.5.8.3.1. Company Overview
5.6. Spain Ivf Services Market, (Revenue And Number of Cycles)
5.6.1. Overview
5.6.2. Market Size And Forecast
5.6.3. Spain Ivf Services Market, By End User
5.6.3.1. Market Size And Forecast
5.6.3.2. Market Volume And Forecast
5.6.3.3. Fertility Clinics
5.6.3.4. Hospitals
5.6.3.5. Surgical Centers
5.6.3.6. Clinical Research Institutes
5.6.4. Spain Ivf Services Market, By Cycle Type
5.6.4.1. Market Size And Forecast
5.6.4.2. Market Volume And Forecast
5.6.4.3. Fresh Ivf Cycles (Non-Donor)
5.6.4.4. Thawed Ivf Cycles (Non-Donor)
5.6.4.5. Donor Egg Ivf Cycles
5.6.5. Market Dynamics
5.6.5.1. Driving Factors
5.6.5.1.1. Increase In The Number of Foreign Patients
5.6.5.2. Restraining Factors
5.6.5.2.1. Limited Awareness And Language Barriers
5.6.6. Regulatory Issues, Legislations And Authorities
5.6.7. Insurance Reimbursement Scenario
5.6.8. Company Profiles
5.6.8.1. Ivf Spain
5.6.8.1.1. Company Overview
5.6.8.2. Euvitro S.L.U.
5.6.8.2.1. Company Overview
5.6.8.3. Fiv Marbella
5.6.8.3.1. Company Overview
5.7. Denmark Ivf Services Market, (Revenue And Number of Cycles)
5.7.1. Overview
5.7.2. Market Size And Forecast
5.7.3. Denmark Ivf Services Market, By End User
5.7.3.1. Market Size And Forecast
5.7.3.2. Market Volume And Forecast
5.7.3.3. Fertility Clinics
5.7.3.4. Hospitals
5.7.3.5. Surgical Centers
5.7.3.6. Clinical Research Institutes
5.7.4. Denmark Ivf Services Market, By Cycle Type
5.7.4.1. Market Size And Forecast
5.7.4.2. Market Volume And Forecast
5.7.4.3. Fresh Ivf Cycles (Non-Donor)
5.7.4.4. Thawed Ivf Cycles (Non-Donor)
5.7.4.5. Donor Egg Ivf Cycles
5.7.5. Market Dynamics
5.7.5.1. Driving Factors
5.7.5.1.1. Increase In Disposable Income
5.7.5.1.2. Advances In Ivf Technology
5.7.5.2. Restraining Factors
5.7.5.2.1. Reimbursement In Public Clinics Only
5.7.6. Regulatory Issues, Legislations And Authorities
5.7.7. Insurance Reimbursement Scenario
5.7.8. Company Profiles
5.7.8.1. Vitanova
5.7.8.1.1. Company Overview
5.7.8.2. Dansk Fertilitetsklinik
5.7.8.2.1. Company Overview
5.7.8.3. Storkklinik (Stork Ivf Clinic)
5.7.8.3.1. Company Overview
5.7.8.4. Trianglen Fertility Clinic
5.7.8.4.1. Company Overview
5.8. Russia Ivf Services Market, (Revenue And Number of Cycles)
5.8.1. Overview
5.8.2. Market Size And Forecast
5.8.3. Russia Ivf Services Market, By End User
5.8.3.1. Market Size And Forecast
5.8.3.2. Market Volume And Forecast
5.8.3.3. Fertility Clinics
5.8.3.4. Hospitals
5.8.3.5. Surgical Centers
5.8.3.6. Clinical Research Institutes
5.8.4. Russia Ivf Services Market, By Cycle Type
5.8.4.1. Market Size And Forecast
5.8.4.2. Market Volume And Forecast
5.8.4.3. Fresh Ivf Cycles (Non-Donor)
5.8.4.4. Thawed Ivf Cycles (Non-Donor)
5.8.4.5. Donor Egg Ivf Cycles
5.8.5. Market Dynamics
5.8.5.1. Driving Factors
5.8.5.1.1. Rising Popularity of Fertility Tourism
5.8.5.2. Restraining Factors
5.8.5.2.1. Language Barrier
5.8.6. Regulatory Issues, Legislations And Authorities
5.8.7. Insurance Reimbursement Scenario
5.8.8. Company Profiles
5.8.8.1. Ava Clinic Scanfert
5.8.8.1.1. Company Overview
5.8.8.2. Md Medical Group
5.8.8.2.1. Company Overview
5.8.8.3. International Centre For Reproductive Medicine, Icrm
5.8.8.3.1. Company Overview
5.9. Rest of Europe Ivf Services Market, (Revenue And Number of Cycles)
5.9.1. Overview
5.9.2. Market Size And Forecast
5.9.3. Rest of Europe Ivf Services Market, By End User
5.9.3.1. Market Size And Forecast
5.9.3.2. Market Volume And Forecast
5.9.3.3. Fertility Clinics
5.9.3.4. Hospitals
5.9.3.5. Surgical Centers
5.9.3.6. Clinical Research Institutes
5.9.4. Rest of Europe Ivf Services Market, By Cycle Type
5.9.4.1. Market Size And Forecast
5.9.4.2. Market Volume And Forecast
5.9.4.3. Fresh Ivf Cycles (Non-Donor)
5.9.4.4. Thawed Ivf Cycles (Non-Donor)
5.9.4.5. Donor Egg Ivf Cycles
5.9.5. Market Dynamics
5.9.5.1. Driving Factors
5.9.5.1.1. Wide Availability of Reimbursements
5.9.5.1.2. Changes In Lifestyle
5.9.5.2. Restraining Factors
5.9.6. Regulatory Issues, Legislations And Authorities
5.9.7. Insurance Reimbursement Scenario
5.9.8. Company Profiles
5.9.8.1. Betamedics
5.9.8.1.1. Company Overview
5.9.8.2. Ova Ivf Clinic Zurich
5.9.8.2.1. Company Overview
5.9.8.3. Vivaneo - Medical Center Kinderwens
5.9.8.3.1. Company Overview
Chapter 6: Asia- Pacific Ivf Services Market
6.1. Overview
6.1.1. Market Size And Forecast
6.1.1.1. By Country
6.1.1.2. By End User
6.1.1.3. By Cycle Type
6.1.2. Market Volume And Forecast
6.1.2.1. By Country
6.1.2.2. By End User
6.1.2.3. By Cycle Type
6.2. India Ivf Services Market, (Revenue And Number of Cycles)
6.2.1. Overview
6.2.2. Market Size And Forecast
6.2.3. Fertility Center In India, 2017
6.2.4. India Ivf Services Market, By End User
6.2.4.1. Market Size And Forecast
6.2.4.2. Market Volume And Forecast
6.2.4.3. Fertility Clinics
6.2.4.4. Hospitals
6.2.4.5. Surgical Centers
6.2.4.6. Clinical Research Institutes
6.2.5. India Ivf Services Market, By Cycle Type
6.2.5.1. Market Size And Forecast
6.2.5.2. Market Volume And Forecast
6.2.5.3. Fresh Ivf Cycles (Non-Donor)
6.2.5.4. Thawed Ivf Cycles (Non-Donor)
6.2.5.5. Donor Egg Ivf Cycles
6.2.6. Market Dynamics
6.2.6.1. Driving Factors
6.2.6.2. Restraining Factors
6.2.7. Regulatory Issues, Legislations And Authorities
6.2.8. Insurance Reimbursement Scenario
6.2.9. Company Profile
6.2.9.1. Bourn Hall Fertility Center
6.2.9.1.1. Company Overview
6.2.9.2. Southend Fertility And Ivf
6.2.9.2.1. Company Overview
6.2.9.3. Morpheus Life Sciences Pvt. Ltd.
6.2.9.3.1. Company Overview
6.2.9.4. Bloom Fertility Center
6.2.9.4.1. Company Overview
6.2.9.5. Bloom Fertility And Healthcare
6.2.9.5.1. Company Overview
6.2.9.6. Manipal Fertility
6.2.9.6.1. Company Overview
6.2.9.7. Cloudnine Fertility
6.2.9.7.1. Company Overview
6.3. China Ivf Services Market, (Revenue And Number of Cycles)
6.3.1. Overview
6.3.2. Market Size And Forecast
6.3.3. China Ivf Services Market, By End User
6.3.3.1. Market Size And Forecast
6.3.3.2. Market Volume And Forecast
6.3.3.3. Fertility Clinics
6.3.3.4. Hospitals
6.3.3.5. Surgical Centers
6.3.3.6. Clinical Research Institutes
6.3.4. China Ivf Services Market, By Cycle Type
6.3.4.1. Market Size And Forecast
6.3.4.2. Market Volume And Forecast
6.3.4.3. Fresh Ivf Cycles (Non-Donor)
6.3.4.4. Thawed Ivf Cycles (Non-Donor)
6.3.4.5. Donor Egg Ivf Cycles
6.3.5. Market Dynamics
6.3.5.1. Driving Factors
6.3.5.2. Restraining Factors
6.3.6. Regulatory Issues, Legislations And Authorities
6.3.7. Insurance Reimbursement Scenario
6.3.8. Company Profile
6.3.8.1. Shanghai Ji Ai Genetics & Ivf Institute
6.3.8.1.1. Company Overview
6.3.8.2. Shanghai United Family Hospital
6.3.8.2.1. Company Overview
6.4. Japan Ivf Services Market, (Revenue And Number of Cycles)
6.4.1. Overview
6.4.2. Market Size And Forecast
6.4.3. Japan Ivf Services Market, By End User
6.4.3.1. Market Size And Forecast
6.4.3.2. Market Volume And Forecast
6.4.3.3. Fertility Clinics
6.4.3.4. Hospitals
6.4.3.5. Surgical Centers
6.4.3.6. Clinical Research Institutes
6.4.4. Japan Ivf Services Market, By Cycle Type
6.4.4.1. Market Size And Forecast
6.4.4.2. Market Volume And Forecast
6.4.4.3. Fresh Ivf Cycles (Non-Donor)
6.4.4.4. Thawed Ivf Cycles (Non-Donor)
6.4.4.5. Donor Egg Ivf Cycles
6.4.5. Market Dynamics
6.4.5.1. Driving Factors
6.4.5.2. Restraining Factors
6.4.6. Regulatory Issues, Legislations And Authorities
6.4.7. Insurance Reimbursement Scenario
6.4.8. Company Profile
6.4.8.1. Ivf Namba Clinic
6.4.8.1.1. Company Overview
6.4.8.2. Sanno Hospital
6.4.8.2.1. Company Overview
6.4.8.3. Oak Medical Group/Oak Clinic
6.4.8.3.1. Company Overview
6.5. Australia Ivf Services Market, (Revenue And Number of Cycles)
6.5.1. Overview
6.5.2. Market Size And Forecast
6.5.3. Fertility Center In Australia, 2017
6.5.4. Australia Ivf Services Market, By End User
6.5.4.1. Market Size And Forecast
6.5.4.2. Market Volume And Forecast
6.5.4.3. Fertility Clinics
6.5.4.4. Hospitals
6.5.4.5. Surgical Centers
6.5.4.6. Clinical Research Institutes
6.5.5. Australia Ivf Services Market, By Cycle Type
6.5.5.1. Market Size And Forecast
6.5.5.2. Market Volume And Forecast
6.5.5.3. Fresh Ivf Cycles (Non-Donor)
6.5.5.4. Thawed Ivf Cycles (Non-Donor)
6.5.5.5. Donor Egg Ivf Cycles
6.5.6. Market Dynamics
6.5.6.1. Driving Factors
6.5.6.2. Restraining Factors
6.5.7. Regulatory Issues, Legislations And Authorities
6.5.8. Insurance Reimbursement Scenario
6.5.9. Company Profile
6.5.9.1. Virtus Health
6.5.9.1.1. Company Overview
6.5.9.2. Monash Ivf Wesley Hospital Auchenflower
6.5.9.2.1. Company Overview
6.5.9.3. Fertility First
6.5.9.3.1. Company Overview
6.5.9.4. Flinders Reproductive Medicine Pty Ltd
6.5.9.4.1. Company Overview
6.6. New Zealand Ivf Services Market, (Revenue And Number of Cycles)
6.6.1. Overview
6.6.2. Market Size And Forecast
6.6.3. New Zealand Ivf Services Market, By End User
6.6.3.1. Market Size And Forecast
6.6.3.2. Market Volume And Forecast
6.6.3.3. Fertility Clinics
6.6.3.4. Hospitals
6.6.3.5. Surgical Centers
6.6.3.6. Clinical Research Institutes
6.6.4. New Zealand Ivf Services Market, By Cycle Type
6.6.4.1. Market Size And Forecast
6.6.4.2. Market Volume And Forecast
6.6.4.3. Fresh Ivf Cycles (Non-Donor)
6.6.4.4. Thawed Ivf Cycles (Non-Donor)
6.6.4.5. Donor Egg Ivf Cycles
6.6.5. Market Dynamics
6.6.5.1. Driving Factors
6.6.5.2. Restraining Factors
6.6.6. Regulatory Issues, Legislations And Authorities
6.6.7. Insurance Reimbursement Scenario
6.6.8. Company Profile
6.6.8.1. Fertility Associates
6.6.8.1.1. Company Overview
6.6.8.2. Genea Oxford Fertility Limited
6.6.8.2.1. Company Overview
6.6.8.3. Repromed
6.6.8.3.1. Company Overview
6.7. South Korea Ivf Services Market, (Revenue And Number of Cycles)
6.7.1. Overview
6.7.2. Market Size And Forecast
6.7.3. Fertility Center In South Korea, 2017
6.7.4. South Korea Ivf Services Market, By End User
6.7.4.1. Market Size And Forecast
6.7.4.2. Market Volume And Forecast
6.7.4.3. Fertility Clinics
6.7.4.4. Hospitals
6.7.4.5. Surgical Centers
6.7.4.6. Clinical Research Institutes
6.7.5. South Korea Ivf Services Market, By Cycle Type
6.7.5.1. Market Size And Forecast
6.7.5.2. Market Volume And Forecast
6.7.5.3. Fresh Ivf Cycles (Non-Donor)
6.7.5.4. Thawed Ivf Cycles (Non-Donor)
6.7.5.5. Donor Egg Ivf Cycles
6.7.6. Market Dynamics
6.7.6.1. Driving Factors
6.7.6.2. Restraining Factors
6.7.7. Regulatory Issues, Legislations And Authorities
6.7.8. Insurance Reimbursement Scenario
6.7.9. Company Profile
6.7.9.1. Cha Fertility Center
6.7.9.1.1. Company Overview
6.7.9.2. Maria Fertility Hospital
6.7.9.2.1. Company Overview
6.8. Thailand Ivf Services Market, (Revenue And Number of Cycles)
6.8.1. Overview
6.8.2. Market Size And Forecast
6.8.3. Thailand Ivf Services Market, By End User
6.8.3.1. Market Size And Forecast
6.8.3.2. Market Volume And Forecast
6.8.3.3. Fertility Clinics
6.8.3.4. Hospitals
6.8.3.5. Surgical Centers
6.8.3.6. Clinical Research Institutes
6.8.4. Thailand Ivf Services Market, By Cycle Type
6.8.4.1. Market Size And Forecast
6.8.4.2. Market Volume And Forecast
6.8.4.3. Fresh Ivf Cycles (Non-Donor)
6.8.4.4. Thawed Ivf Cycles (Non-Donor)
6.8.4.5. Donor Egg Ivf Cycles
6.8.5. Market Dynamics
6.8.5.1. Driving Factors
6.8.5.2. Restraining Factors
6.8.6. Regulatory Issues, Legislations And Authorities
6.8.7. Insurance Reimbursement Scenario
6.8.8. Company Profile
6.8.8.1. Safe Fertility Center
6.8.8.1.1. Company Overview
6.8.8.2. Bangkok Ivf Center (Bangkok Hospital)
6.8.8.2.1. Company Overview
6.8.8.3. Bangkok Ivf Center
6.8.8.3.1. Company Overview
6.9. Rest of Asia-Pacific Ivf Services Market, (Revenue And Number of Cycles)
6.9.1. Overview
6.9.2. Market Size And Forecast
6.9.3. Rest of Asia-Pacific Ivf Services Market, By End User
6.9.3.1. Market Size And Forecast
6.9.3.2. Market Volume And Forecast
6.9.3.3. Fertility Clinics
6.9.3.4. Hospitals
6.9.3.5. Surgical Centers
6.9.3.6. Clinical Research Institutes
6.9.4. Rest of Asia-Pacific Ivf Services Market, By Cycle Type
6.9.4.1. Market Size And Forecast
6.9.4.2. Market Volume And Forecast
6.9.4.3. Fresh Ivf Cycles (Non-Donor)
6.9.4.4. Thawed Ivf Cycles (Non-Donor)
6.9.4.5. Donor Egg Ivf Cycles
6.9.5. Market Dynamics
6.9.5.1. Driving Factors
6.9.5.2. Restraining Factors
6.9.6. Regulatory Issues, Legislations And Authorities
6.9.7. Insurance Reimbursement Scenario
6.9.8. Company Profile
6.9.8.1. Center For Advanced Reproductive Medicine And Infertility
6.9.8.1.1. Company Overview
6.9.8.2. Thomson Medical Pte. Ltd.
6.9.8.2.1. Company Overview
6.9.8.3. Kl Fertility & Gynaecology Centre
6.9.8.3.1. Company Overview
Chapter 7: LAMEA Ivf Services Market
7.1. Overview
7.1.1. Market Size And Forecast
7.1.1.1. By Country
7.1.1.2. By End User
7.1.1.3. By Cycle Type
7.1.2. Market Volume And Forecast
7.1.2.1. By Country
7.1.2.2. By End User
7.1.2.3. By Cycle Type
7.2. Latin America Ivf Services Market, (Revenue And Number of Cycles)
7.2.1. Overview
7.2.2. Market Size And Forecast
7.2.3. Fertility Center In Latin America, 2017
7.2.4. Latin America Ivf Services Market, By End User
7.2.4.1. Market Size And Forecast
7.2.4.2. Market Volume And Forecast
7.2.4.3. Fertility Clinics
7.2.4.4. Hospitals
7.2.4.5. Surgical Centers
7.2.4.6. Clinical Research Institutes
7.2.5. Latin America Ivf Services Market, By Cycle Type
7.2.5.1. Market Size And Forecast
7.2.5.2. Market Volume And Forecast
7.2.5.3. Fresh Ivf Cycles (Non-Donor)
7.2.5.4. Thawed Ivf Cycles (Non-Donor)
7.2.5.5. Donor Egg Ivf Cycles
7.2.6. Market Dynamics
7.2.6.1. Driving Factors
7.2.6.2. Restraining Factors
7.2.7. Regulatory Issues, Legislations And Authorities
7.2.8. Insurance Reimbursement Scenario
7.2.9. Company Profile
7.2.9.1. Ivi Panama
7.2.9.1.1. Company Overview
7.2.9.2. Ivf Panama Center For Reproduction Punta Pacfica
7.2.9.2.1. Company Overview
7.2.9.3. The Hugh Wynter Fertility Management Unit
7.2.9.3.1. Company Overview
7.3. Middle East Ivf Services Market, (Revenue And Number of Cycles)
7.3.1. Overview
7.3.2. Market Size And Forecast
7.3.3. Fertility Center In Middle East, 2017
7.3.4. Middle East Ivf Services Market, By End User
7.3.4.1. Market Size And Forecast
7.3.4.2. Market Volume And Forecast
7.3.4.3. Fertility Clinics
7.3.4.4. Hospitals
7.3.4.5. Surgical Centers
7.3.4.6. Clinical Research Institutes
7.3.5. Middle East Ivf Services Market, By Cycle Type
7.3.5.1. Market Size And Forecast
7.3.5.2. Market Volume And Forecast
7.3.5.3. Fresh Ivf Cycles (Non-Donor)
7.3.5.4. Thawed Ivf Cycles (Non-Donor)
7.3.5.5. Donor Egg Ivf Cycles
7.3.6. Market Dynamics
7.3.6.1. Driving Factors
7.3.6.2. Restraining Factors
7.3.7. Regulatory Issues, Legislations And Authorities
7.3.8. Insurance Reimbursement Scenario
7.3.9. Company Profile
7.3.9.1. Cyprus Ivf Centre
7.3.9.1.1. Company Overview
7.3.9.2. Bourn Hall International
7.3.9.2.1. Company Overview
7.3.9.3. Fakih Ivf Fertility Center
7.3.9.3.1. Company Overview
7.4. Africa Ivf Services Market, (Revenue And Number of Cycles)
7.4.1. Overview
7.4.2. Market Size And Forecast
7.4.3. Fertility Center In Africa, 2016
7.4.4. Africa Ivf Services Market, By End User
7.4.4.1. Market Size And Forecast
7.4.4.2. Market Volume And Forecast
7.4.4.3. Fertility Clinics
7.4.4.4. Hospitals
7.4.4.5. Surgical Centers
7.4.4.6. Clinical Research Institutes
7.4.5. Africa Ivf Services Market, By Cycle Type
7.4.5.1. Market Size And Forecast
7.4.5.2. Market Volume And Forecast
7.4.5.3. Fresh Ivf Cycles (Non-Donor)
7.4.5.4. Thawed Ivf Cycles (Non-Donor)
7.4.5.5. Donor Egg Ivf Cycles
7.4.6. Market Dynamics
7.4.6.1. Driving Factors
7.4.6.2. Restraining Factors
7.4.7. Regulatory Issues, Legislations And Authorities
7.4.8. Insurance Reimbursement Scenario
7.4.9. Company Profile
7.4.9.1. Medfem Fertility Clinic
7.4.9.1.1. Company Overview
7.4.9.2. The Cape Fertility Clinic
7.4.9.2.1. Company Overview
7.4.9.3. Lifesure Fertility And Gynaecology Centre
7.4.9.3.1. Company Overview
*Full List of Tables and Figures Available on Enquiry.

Executive Summary

In-vitro Fertilization (IVF) Services Report forecasts that the global market is expected to garner market to reach $11.3 billion by 2021.United Stateswould continue to lead the market through 2021 and would have 321.7 thousand IVF cycles performed in 2021. Globally,Indiais projected to register highest growth both in terms of number of cycles and revenue.

The key factors that influence the growth of IVF cycles include, delayed pregnancy; a factor that is increasingly gaining prominence in developed economies, rise in infertility rates and increase in healthcare expenditures. Moreover, growing acceptance of the 3-parent IVF technique further contributing to the market growth. These factors would facilitate the number of cycles performed to reach 3,122.2 thousands by 2021, globally. On contrary, stringent regulations, limited success ratio and high costs of treatment would limit the market growth. Active initiatives by government, such as IVF refund programs, donor egg IVF programs, development of cost-effective IVF techniques and increasing popularity of fertility tourism would spur the market growth.

Geographically,the United States,China, andIndia, collectively holds about 42% of the market (IVF cycles) share due to increased rate of infertility and practices of embryo banking cycles, rising fertility tourism, and delayed parenthood decisions. On the other hand, Turkey, Israel, Brazil, Mexicowould emerge as key fertility tourism destinations during the forecast period mainly due to favorable government regulations and economic availability of skilled workforce and hospitality services.

Key Findings of In-vitro Fertilization (IVF) Services Market:
In India, fertility clinics and hospitals segment collectively accounted for about 4/5th of the revenue generated in 2014
Middle East accounted for about 65% revenue share of the LAMEA IVF market
The Asia-Pacific IVF market is expected to grow at a promising CAGR of 8.9% from 2015 to 2021 in terms of volume
China leads the Asia Pacific IVF market with about 44% volume share

Key players profiled in this report included Fertility and Gynecology Center, Monterey Bay IVF, Conceptions Reproductive Associates, Toronto Center for Advanced reproductive Technology Ltd., Liv Fertility Center inPuerto Vallarta, Klinikum Stuttgart, Heidelberg University Hospital, Clinique de la Muette, The Bridge Center,Sun Pharmaceuticals, Cadila Healthcare Ltd., LG Lifesciences, Vitrolife AB., EMD Serono, Inc., Thermo Fisher Scientific Inc., Genea Biomedx, Clinica Anglo Americana, Cyprus IVF Center Lifesure Fertility & Gynecology Center and others.

Companies Mentioned

  • Gynecology Center
  • Monterey Bay IVF
  • Conceptions Reproductive Associates
  • Toronto Center for Advanced reproductive Technology Ltd.
  • Liv Fertility Center inPuerto Vallarta
  • Klinikum Stuttgart
  • Heidelberg University Hospital
  • Clinique de la

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Related Topics

Related Reports

IVF Services Global Market Report 2024 - Product Image

IVF Services Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Global Donor Egg IVF Services Market (2023-2028) by Type, End User, Geography, Competitive Analysis, and Impact of Covid-19, Ansoff Analysis - Product Image

Global Donor Egg IVF Services Market (2023-2028) by Type, End User, Geography, Competitive Analysis, and Impact of Covid-19, Ansoff Analysis

  • Report
  • 168 Pages
  • Global
From
Global In-Vitro Fertilization (IVF) Services Market (2023-2028) by Product, Cycle, Type, End-User, Geography, Competitive Analysis, and Impact of Covid-19, Ansoff Analysis - Product Image

Global In-Vitro Fertilization (IVF) Services Market (2023-2028) by Product, Cycle, Type, End-User, Geography, Competitive Analysis, and Impact of Covid-19, Ansoff Analysis

  • Report
  • 176 Pages
  • Global
From
In-Vitro Fertilization Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Technique (ICSI IVF, Non-ICSI/ Traditional IVF), By Product, By Egg Donor, By Infertility, By Infertility, By Region and Competition - Product Image

In-Vitro Fertilization Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Technique (ICSI IVF, Non-ICSI/ Traditional IVF), By Product, By Egg Donor, By Infertility, By Infertility, By Region and Competition

  • Report
  • 117 Pages
  • Global
From
Global Donor Egg IVF Services Market by Type (Fresh Donor Eggs, Frozen Donor Eggs), End-user (Fertility Clinics, Hospitals) - Forecast 2024-2030 - Product Image

Global Donor Egg IVF Services Market by Type (Fresh Donor Eggs, Frozen Donor Eggs), End-user (Fertility Clinics, Hospitals) - Forecast 2024-2030

  • Report
  • 192 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.